<p>Monte Rosa’s NEK7-targeting drug pulled several heart-risk biomarkers toward healthy levels in 108 people with obesity. Think of NLRP3 as a fire alarm wired into your immune cells. When it trips, cells burst open and spill out a cocktail of inflammatory signals. That response is handy during an infe</p>